What is the RE-JOIN Consortium?
The Restoring Joint Health and Function to Reduce Pain (RE-JOIN) Consortium will be a new program within The NIH Helping to End Addiction Long-term (HEAL) Initiative. The goal of RE-JOIN will be to define the innervation of the different articular and peri-articular tissues that collectively form the joint (including bone, cartilage, synovium, joint capsule, ligament, tendon, fascia and muscle), by sensory neurons that mediate the sensation of pain. Knowledge about the types and distribution of neurites in joint tissues will facilitate the identification of key receptors and mediators that induce pain by activating specific sensory neurons. These mediators and their receptors will provide novel targets for reducing pain.
RE-JOIN Funding Opportunity Announcements
- HEAL Initiative: Restoring Joint Health and Function to Reduce Pain Consortium (RE-JOIN) (UC2 Clinical Trial Not Allowed) (RFA-AR-22-009)
- Notice of Intent to Publish a Funding Opportunity Announcement for HEAL Initiative: Restoring Joint Health and Function to Reduce Pain Consortium (RE-JOIN) (UC2 Clinical Trial Not Allowed) (NOT-AR-22-015)
RE-JOIN Technical Assistance Webinar Information
The intent of the webinar is to provide an overview of the FOA and to address questions pertinent to preparing applications. The webinar is optional and not required for application submission. To access the webinar, you must register using the link below.
Date: Wednesday, February 9, 2022
Time: 11:00 am-12:00pm ET
Prospective applicants are encouraged to submit their questions regarding the FOA in advance of the webinar to email@example.com. Please indicate "RE-JOIN Webinar" in the subject line of your email.